Reevaluating Erythropoiesis-Stimulating Agents.

被引：0
作者：
Kestenbaum, Bryan [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1742 / 1742
页数：1
相关论文
共 3 条
  • [1] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [2] Expression and function of erythropoietin receptors in tumors - Implications for the use of erythropoiesis-stimulating agents in cancer patients
    Sinclair, Angus M.
    Todd, Marque D.
    Forsythe, Kevin
    Knox, Susan J.
    Elliott, Steve
    Begley, C. Glenn
    [J]. CANCER, 2007, 110 (03) : 477 - 488
  • [3] Erythropoiesis-Stimulating Agents - Time for a Reevaluation
    Unger, Ellis F.
    Thompson, Aliza M.
    Blank, Melanie J.
    Temple, Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (03) : 189 - 192
1